455 related articles for article (PubMed ID: 25636579)
1. Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.
Kuśnierczyk P; Mozer-Lisewska I; Zwolińska K; Kowala-Piaskowska AE; Bura M; Bereszyńska I; Pauli A; Żeromski J
Hum Immunol; 2015 Mar; 76(2-3):102-8. PubMed ID: 25636579
[TBL] [Abstract][Full Text] [Related]
2. Association of killer cell immunoglobulin-like receptors with spontaneous clearance of hepatitis C virus in the Chinese population.
Shan Z; Huang J; Liao Q; Huang K; Wang M; Xu R; Tang X; Zhang W; Nelson K; Fu Y; Li C; Rong X
Transfusion; 2018 Apr; 58(4):1028-1035. PubMed ID: 29446443
[TBL] [Abstract][Full Text] [Related]
3. Genetic (KIR, HLA-C) and Some Clinical Parameters Influencing the Level of Liver Enzymes and Early Virologic Response in Patients with Chronic Hepatitis C.
Mozer-Lisewska I; Zwolińska K; Kowala-Piaskowska AE; Bura M; Rozpłochowski B; Pauli A; Żeromski J; Piasecki E; Kuśnierczyk P
Arch Immunol Ther Exp (Warsz); 2016 Feb; 64(1):65-73. PubMed ID: 26206121
[TBL] [Abstract][Full Text] [Related]
4. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.
Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA
Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398
[TBL] [Abstract][Full Text] [Related]
5. Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.
Askar M; Avery R; Corey R; Lopez R; Thomas D; Pidwell D; Eghtesad B; Miller C; Fung J; Zein NN
Liver Transpl; 2009 Nov; 15(11):1557-63. PubMed ID: 19877200
[TBL] [Abstract][Full Text] [Related]
6. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
7. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
[TBL] [Abstract][Full Text] [Related]
8. Frequency of killer cell immunoglobulin-like receptors (KIRs) in Korean patients with chronic HCV infection.
Sung PS; Choi HB; Kim SY; Hong SW; Park CH; Song MJ; Lee SW; Yoo CR; Choi SW; Han NI; Kim TG; Yoon SK
J Korean Med Sci; 2011 Nov; 26(11):1483-8. PubMed ID: 22065905
[TBL] [Abstract][Full Text] [Related]
9. Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients.
Ursu LD; Calenic B; Diculescu M; Dima A; Stoian IT; Constantinescu I
Int J Immunogenet; 2021 Feb; 48(1):16-24. PubMed ID: 32961633
[TBL] [Abstract][Full Text] [Related]
10. Killer Cell Immunoglobulin-Like Receptor Genotypes and Haplotypes Contribute to Susceptibility to Hepatitis B Virus and Hepatitis C Virus Infection in Cameroon.
Torimiro J; Yengo CK; Bimela JS; Tiedeu AB; Lebon PA; Sake CS; Kouanfack C; Nchinda G; Rowland-Jones S; Yindom LM
OMICS; 2020 Feb; 24(2):110-115. PubMed ID: 31977279
[TBL] [Abstract][Full Text] [Related]
11. Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a.
Vejbaesya S; Nonnoi Y; Tanwandee T; Srinak D
J Med Virol; 2011 Oct; 83(10):1733-7. PubMed ID: 21755501
[TBL] [Abstract][Full Text] [Related]
12. Chimpanzee susceptibility to hepatitis C virus infection correlates with presence of Pt-KIR3DS2 and Pt-KIR2DL9: paired activating and inhibitory natural killer cell receptors.
Abi-Rached L; Guethlein LA; Norman PJ; Parham P
Immunogenetics; 2015 Oct; 67(10):625-8. PubMed ID: 26260270
[TBL] [Abstract][Full Text] [Related]
13. Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.
De Re V; Caggiari L; De Zorzi M; Repetto O; Zignego AL; Izzo F; Tornesello ML; Buonaguro FM; Mangia A; Sansonno D; Racanelli V; De Vita S; Pioltelli P; Vaccher E; Berretta M; Mazzaro C; Libra M; Gini A; Zucchetto A; Cannizzaro R; De Paoli P
PLoS One; 2015; 10(2):e0117420. PubMed ID: 25700262
[TBL] [Abstract][Full Text] [Related]
14. HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma.
Cariani E; Pilli M; Zerbini A; Rota C; Olivani A; Zanelli P; Zanetti A; Trenti T; Ferrari C; Missale G
Clin Cancer Res; 2013 Oct; 19(19):5465-73. PubMed ID: 23938290
[TBL] [Abstract][Full Text] [Related]
15. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
[TBL] [Abstract][Full Text] [Related]
16. Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.
Vidal-Castiñeira JR; López-Vázquez A; Díaz-Peña R; Alonso-Arias R; Martínez-Borra J; Pérez R; Fernández-Suárez J; Melón S; Prieto J; Rodrigo L; López-Larrea C
J Virol; 2010 Jan; 84(1):475-81. PubMed ID: 19846535
[TBL] [Abstract][Full Text] [Related]
17. HLA Alleles and KIR Genes in Romanian Patients with Chronic Hepatitis C.
Ursu L; Calenic B; Diculescu M; Dima A; Constantinescu I
J Gastrointestin Liver Dis; 2020 Oct; 29(4):595-601. PubMed ID: 33118540
[TBL] [Abstract][Full Text] [Related]
18. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
[TBL] [Abstract][Full Text] [Related]
19. Killer-cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class I genetic diversity in four South African populations.
Gentle NL; Loubser S; Paximadis M; Puren A; Tiemessen CT
Hum Immunol; 2017; 78(7-8):503-509. PubMed ID: 28571758
[TBL] [Abstract][Full Text] [Related]
20. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
